BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 18355912)

  • 1. Expansion of hepatitis C-specific CD4+CD25+ regulatory T cells after viral clearance: a mechanism to limit collateral damage?
    Godkin A; Ng WF; Gallagher K; Betts G; Thomas HC; Lechler RI
    J Allergy Clin Immunol; 2008 May; 121(5):1277-1284.e3. PubMed ID: 18355912
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXP3 expression in hepatitis C virus-specific CD4+ T cells during acute hepatitis C.
    Heeg MH; Ulsenheimer A; Grüner NH; Zachoval R; Jung MC; Gerlach JT; Raziorrouh B; Schraut W; Horster S; Kauke T; Spannagl M; Diepolder HM
    Gastroenterology; 2009 Oct; 137(4):1280-8.e1-6. PubMed ID: 19596013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunomodulatory role for CD4(+)CD25(+) regulatory T lymphocytes in hepatitis C virus infection.
    Cabrera R; Tu Z; Xu Y; Firpi RJ; Rosen HR; Liu C; Nelson DR
    Hepatology; 2004 Nov; 40(5):1062-71. PubMed ID: 15486925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virus-specific effector CD4+ T-cell responses in hemodialysis patients with hepatitis C virus infection.
    Rico MA; Ruiz S; Subirá D; Barril G; Cigarrán S; Castañón S; Quiroga JA; Selgas R; Carreño V
    J Med Virol; 2004 Jan; 72(1):66-74. PubMed ID: 14635013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of novel HLA-DR11-restricted HCV epitopes reveals both qualitative and quantitative differences in HCV-specific CD4+ T cell responses in chronically infected and non-viremic patients.
    Godkin A; Jeanguet N; Thursz M; Openshaw P; Thomas H
    Eur J Immunol; 2001 May; 31(5):1438-46. PubMed ID: 11465100
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Core-specific adaptive regulatory T-cells in different outcomes of hepatitis C.
    Langhans B; Braunschweiger I; Arndt S; Schulte W; Satoguina J; Layland LE; Vidovic N; Hoerauf A; Oldenburg J; Sauerbruch T; Spengler U
    Clin Sci (Lond); 2010 Apr; 119(2):97-109. PubMed ID: 20222873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional suppression by FoxP3+CD4+CD25(high) regulatory T cells during acute hepatitis C virus infection.
    Smyk-Pearson S; Golden-Mason L; Klarquist J; Burton JR; Tester IA; Wang CC; Culbertson N; Vandenbark AA; Rosen HR
    J Infect Dis; 2008 Jan; 197(1):46-57. PubMed ID: 18171284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated CD4+/CD25+ T-cell frequency and function during hepatitis C virus recurrence after liver transplantation.
    Perrella A; Arenga G; Pisaniello D; Rampone B; Di Costanzo GG; Atripaldi L; Esposito C; Di Florio E; Perrella O; Cuomo O
    Transplant Proc; 2009 Jun; 41(5):1761-6. PubMed ID: 19545723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages.
    Rosen HR; Miner C; Sasaki AW; Lewinsohn DM; Conrad AJ; Bakke A; Bouwer HG; Hinrichs DJ
    Hepatology; 2002 Jan; 35(1):190-8. PubMed ID: 11786976
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cells with a CD4+CD25+ regulatory phenotype suppress in vitro proliferation of virus-specific CD8+ T cells during chronic hepatitis C virus infection.
    Boettler T; Spangenberg HC; Neumann-Haefelin C; Panther E; Urbani S; Ferrari C; Blum HE; von Weizsäcker F; Thimme R
    J Virol; 2005 Jun; 79(12):7860-7. PubMed ID: 15919940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating Toll-like receptor (TLR) 2, TLR4, and regulatory T cells in patients with chronic hepatitis C.
    Wang JP; Zhang Y; Wei X; Li J; Nan XP; Yu HT; Li Y; Wang PZ; Bai XF
    APMIS; 2010 Apr; 118(4):261-70. PubMed ID: 20402671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased frequency of CD56Bright NK-cells, CD3-CD16+CD56- NK-cells and activated CD4+T-cells or B-cells in parallel with CD4+CDC25High T-cells control potentially viremia in blood donors with HCV.
    Zarife MA; Reis EA; Carmo TM; Lopes GB; Brandão EC; Silva HR; Santana N; Martins-Filho OA; Reis MG
    J Med Virol; 2009 Jan; 81(1):49-59. PubMed ID: 19031471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preservation of intrahepatic hepatitis C virus (HCV)-specific CD4+ T cell responses despite global loss of CD4+ T cells in HCV/HIV coinfection.
    Morishima C; Shuhart MC; Yoshihara CS; Paschal DM; Silva MA; Thomassen LV; Emerson SS; Gretch DR
    J Infect Dis; 2007 Aug; 196(4):577-86. PubMed ID: 17624844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel assay for detection of hepatitis C virus-specific effector CD4(+) T cells via co-expression of CD25 and CD134.
    Keoshkerian E; Helbig K; Beard M; Zaunders J; Seddiki N; Kelleher A; Hampartzoumian T; Zekry A; Lloyd AR
    J Immunol Methods; 2012 Jan; 375(1-2):148-58. PubMed ID: 22019644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clearance of hepatitis C viremia associated with cellular immunity in the absence of seroconversion in the hepatitis C incidence and transmission in prisons study cohort.
    Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber PS; Marinos G; Levy MH; Kaldor JM; Dolan KA; Ffrench RA; Lloyd AR; Rawlinson WD;
    J Infect Dis; 2004 May; 189(10):1846-55. PubMed ID: 15122521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective study of viral clearance and CD4(+) T-cell response in acute hepatitis C primary infection and reinfection.
    Aberle JH; Formann E; Steindl-Munda P; Weseslindtner L; Gurguta C; Perstinger G; Grilnberger E; Laferl H; Dienes HP; Popow-Kraupp T; Ferenci P; Holzmann H
    J Clin Virol; 2006 May; 36(1):24-31. PubMed ID: 16483838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the relationship between cytokine secretion and proliferative capacity in hepatitis C virus infection.
    Semmo N; Krashias G; Willberg C; Klenerman P
    J Viral Hepat; 2007 Jul; 14(7):492-502. PubMed ID: 17576391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus core protein triggers expansion and activation of CD4(+)CD25(+) regulatory T cells in chronic hepatitis C patients.
    Zhai N; Chi X; Li T; Song H; Li H; Jin X; Crispe IN; Su L; Niu J; Tu Z
    Cell Mol Immunol; 2015 Nov; 12(6):743-9. PubMed ID: 25531392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women.
    Della Bella S; Riva A; Tanzi E; Nicola S; Amendola A; Vecchi L; Nebbia G; Longhi R; Zanetti AR; Villa ML
    J Hepatol; 2005 Sep; 43(3):394-402. PubMed ID: 16023248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.